Vision Testing in Patients With Partial Seizures Receiving Either Lyrica or Placebo

Completed · Phase 4 · Has a placebo group

Conditions studied: Epilepsies, Partial

In brief

Patients with partial seizures currently taking 1-3 antiepileptic medications will have a 50:50 chance to receive Lyrica 300 mg per day or placebo (no active ingredients) added on to their current medications for 3 months. Neither the study doctor nor the patient will know the medication assignment. Vision testing will be performed prior to receiving the study treatment and at the end of the study to see if there are any changes.

Key facts

Study ID

NCT00351611

Run by

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

People needed

187

Starts

2006-07-26

Expected to finish

2020-02-04

Last updated by the study team

2021-04-13

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Epilepsy partial seizure subjects.
• Currently taking 1 to 3 antiepileptic drugs.

You may not qualify if…

• Pre-existing eye diseases (glaucoma).
• Insufficient response to pregabalin in the treatment of partial seizure, or patients currently receiving pregabalin treatment.

Where it is running

• Premier Medical Group — Mobile, Alabama, United States
• Neurology Clinic, PC — Northport, Alabama, United States
• North River Ophthalmology — Tuscaloosa, Alabama, United States
• Western Neurosurgery — Tucson, Arizona, United States
• Office of Robert Snyder, MD — Tucson, Arizona, United States
• REM Medical Clinical Research — Tucson, Arizona, United States
• NEA Baptist Clinic - Clinical Research Center — Jonesboro, Arkansas, United States
• NEA Baptist Clinic — Jonesboro, Arkansas, United States
• NEA Baptst Clinic — Jonesboro, Arkansas, United States
• Chenal MRI — Little Rock, Arkansas, United States
• Clinical Trials, Inc. — Little Rock, Arkansas, United States
• Eye Care Arkansas — Little Rock, Arkansas, United States
• Radiology Consultants — Little Rock, Arkansas, United States
• University of Arkansas for Medical Sciences — Little Rock, Arkansas, United States
• Barbara Swartz, MD, Inc — Costa Mesa, California, United States
• Mireille P. Hamparian — Glendale, California, United States
• Lakeside Vision Center — Irvine, California, United States
• Eye Treatment Center, Inc. — Long Beach, California, United States
• Hoag Memorial Hospital Presbyterian — Newport Beach, California, United States
• Clinical Innovations, Inc. — Paramount, California, United States
• Yale University School of Medicine — New Haven, Connecticut, United States
• Bradenton Research Center, Inc — Bradenton, Florida, United States
• The Eye Associates — Bradenton, Florida, United States
• SJS Clinical Research, Inc. — Destin, Florida, United States
• Neurology Center, P.C. — Mobile, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.